Shenzhen Kangtai Biological Products Co., Ltd. researches, develops, produces, and sells various types of human vaccines in China. The company’s products include cell-free whitebait b-type haemophilus influenzae combined vaccine, SARS-COV-2 vaccine, recombinant hepatitis B vaccine, 23-valent pneumococcal polysaccharide vaccine, diphtheria tetanus acellular pertussis and haemophilus influenzae type b combined vaccine, haemophilus influenzae type b conjugate vaccine, measles and rubella combined vaccine, 13-valent pneumococcal conjugate vaccine, rabies vaccine, inactivated poliomyelitis vaccine, live attenuated varicella vaccine, and HIB conjugate vaccine. Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1992 and is based in Shenzhen, China.
Metrics to compare | 300601 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300601PeersSector | |
---|---|---|---|---|
P/E Ratio | 28.3x | 24.2x | −0.6x | |
PEG Ratio | 0.29 | 0.12 | 0.00 | |
Price/Book | 1.5x | 2.0x | 2.6x | |
Price / LTM Sales | 5.0x | 4.7x | 3.1x | |
Upside (Analyst Target) | 89.2% | 43.7% | 57.2% | |
Fair Value Upside | Unlock | 40.2% | 7.3% | Unlock |